 Vibha Sharma
Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Neoplasms | 11 | 2023 | 309 | 1.190 |
Why?
| | Retinoid X Receptors | 7 | 2011 | 40 | 0.590 |
Why?
| | Retinoids | 5 | 2011 | 33 | 0.510 |
Why?
| | Thyroid Gland | 3 | 2011 | 94 | 0.380 |
Why?
| | Thyroid Carcinoma, Anaplastic | 2 | 2023 | 35 | 0.360 |
Why?
| | Receptors, Calcitriol | 1 | 2010 | 53 | 0.340 |
Why?
| | Calcitriol | 1 | 2010 | 53 | 0.340 |
Why?
| | Pituitary Gland | 2 | 2011 | 148 | 0.320 |
Why?
| | Hypothalamus | 2 | 2011 | 145 | 0.320 |
Why?
| | Receptors, Retinoic Acid | 3 | 2004 | 51 | 0.290 |
Why?
| | Carcinoma | 3 | 2009 | 215 | 0.200 |
Why?
| | Cell Line, Tumor | 11 | 2019 | 3178 | 0.200 |
Why?
| | Proto-Oncogene Proteins B-raf | 2 | 2023 | 212 | 0.180 |
Why?
| | Transcription Factors | 2 | 2004 | 1635 | 0.160 |
Why?
| | Focal Adhesion Kinase 1 | 2 | 2016 | 29 | 0.150 |
Why?
| | Adenocarcinoma, Follicular | 1 | 2019 | 34 | 0.150 |
Why?
| | Gene Expression | 1 | 2004 | 1455 | 0.150 |
Why?
| | Adrenal Cortex | 1 | 2018 | 27 | 0.150 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 259 | 0.140 |
Why?
| | Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2018 | 33 | 0.140 |
Why?
| | Benzoates | 3 | 2009 | 41 | 0.140 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2019 | 200 | 0.140 |
Why?
| | Adrenal Cortex Neoplasms | 1 | 2018 | 60 | 0.140 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2014 | 941 | 0.140 |
Why?
| | Adrenocortical Carcinoma | 1 | 2018 | 63 | 0.140 |
Why?
| | Thiazolidinediones | 2 | 2009 | 137 | 0.130 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2019 | 431 | 0.120 |
Why?
| | Antineoplastic Agents | 4 | 2012 | 2042 | 0.110 |
Why?
| | Genes, Tumor Suppressor | 1 | 2014 | 86 | 0.110 |
Why?
| | Thiazoles | 1 | 2012 | 115 | 0.090 |
Why?
| | src-Family Kinases | 1 | 2012 | 95 | 0.090 |
Why?
| | Tetrahydronaphthalenes | 2 | 2009 | 29 | 0.090 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 2010 | 15 | 0.090 |
Why?
| | Steroid Hydroxylases | 1 | 2010 | 22 | 0.090 |
Why?
| | Vitamin D3 24-Hydroxylase | 1 | 2010 | 15 | 0.090 |
Why?
| | Cell Survival | 2 | 2012 | 1076 | 0.090 |
Why?
| | 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2010 | 18 | 0.090 |
Why?
| | Blotting, Western | 3 | 2014 | 1170 | 0.090 |
Why?
| | Thyroxine | 2 | 2011 | 62 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2014 | 732 | 0.080 |
Why?
| | Bone Neoplasms | 1 | 2012 | 231 | 0.080 |
Why?
| | MAP Kinase Kinase 2 | 1 | 2009 | 29 | 0.080 |
Why?
| | Cell Proliferation | 6 | 2019 | 2345 | 0.080 |
Why?
| | Mice | 9 | 2019 | 16620 | 0.080 |
Why?
| | Proto-Oncogene Proteins pp60(c-src) | 1 | 2009 | 12 | 0.080 |
Why?
| | MAP Kinase Kinase 1 | 1 | 2009 | 76 | 0.080 |
Why?
| | Focal Adhesion Protein-Tyrosine Kinases | 1 | 2009 | 35 | 0.080 |
Why?
| | RNA, Messenger | 3 | 2005 | 2679 | 0.080 |
Why?
| | Dasatinib | 2 | 2023 | 51 | 0.080 |
Why?
| | Pyrimidines | 1 | 2012 | 449 | 0.080 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2010 | 749 | 0.080 |
Why?
| | Carcinoma, Papillary | 1 | 2009 | 76 | 0.080 |
Why?
| | Benzodioxoles | 1 | 2009 | 105 | 0.070 |
Why?
| | PPAR gamma | 2 | 2009 | 182 | 0.070 |
Why?
| | Quinazolines | 1 | 2009 | 243 | 0.070 |
Why?
| | Polymorphism, Genetic | 1 | 2010 | 639 | 0.070 |
Why?
| | MAP Kinase Signaling System | 1 | 2009 | 307 | 0.070 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2009 | 216 | 0.070 |
Why?
| | Vitamin D | 1 | 2010 | 380 | 0.070 |
Why?
| | Base Sequence | 1 | 2010 | 2137 | 0.070 |
Why?
| | Mice, Nude | 3 | 2016 | 678 | 0.070 |
Why?
| | Tumor Cells, Cultured | 2 | 2009 | 930 | 0.060 |
Why?
| | Iodide Peroxidase | 1 | 2005 | 28 | 0.060 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2005 | 131 | 0.060 |
Why?
| | Thyrotropin | 1 | 2005 | 109 | 0.060 |
Why?
| | Retinoid X Receptor gamma | 1 | 2004 | 4 | 0.060 |
Why?
| | Heterografts | 2 | 2016 | 129 | 0.060 |
Why?
| | Organic Chemicals | 1 | 2005 | 128 | 0.060 |
Why?
| | Animals | 9 | 2019 | 34647 | 0.060 |
Why?
| | Mutation | 2 | 2019 | 3696 | 0.060 |
Why?
| | Lipoprotein Lipase | 1 | 2004 | 58 | 0.050 |
Why?
| | Transfection | 1 | 2005 | 896 | 0.050 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2023 | 81 | 0.050 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2009 | 1349 | 0.050 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2012 | 812 | 0.050 |
Why?
| | Apoptosis | 3 | 2012 | 2437 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2004 | 378 | 0.050 |
Why?
| | Dietary Fats | 1 | 2004 | 301 | 0.050 |
Why?
| | Cell Division | 1 | 2004 | 777 | 0.050 |
Why?
| | Melanoma | 1 | 2009 | 724 | 0.050 |
Why?
| | Humans | 13 | 2023 | 128499 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2023 | 420 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 1951 | 0.050 |
Why?
| | Promoter Regions, Genetic | 1 | 2005 | 1199 | 0.050 |
Why?
| | Cell Cycle | 1 | 2004 | 581 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2005 | 2069 | 0.040 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 1562 | 0.040 |
Why?
| | Cell Line | 1 | 2005 | 2741 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2014 | 757 | 0.040 |
Why?
| | Neoplasm Transplantation | 1 | 2019 | 257 | 0.040 |
Why?
| | Aldosterone | 1 | 2018 | 43 | 0.040 |
Why?
| | Liver | 1 | 2005 | 1827 | 0.030 |
Why?
| | Germ-Line Mutation | 1 | 2018 | 138 | 0.030 |
Why?
| | Cell Growth Processes | 1 | 2016 | 52 | 0.030 |
Why?
| | Phosphorylation | 2 | 2012 | 1686 | 0.030 |
Why?
| | Signal Transduction | 3 | 2016 | 4825 | 0.030 |
Why?
| | Time Factors | 1 | 2005 | 6506 | 0.030 |
Why?
| | Ligands | 2 | 2009 | 617 | 0.030 |
Why?
| | Carcinogenesis | 1 | 2016 | 213 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2004 | 1624 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2016 | 610 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2014 | 128 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2012 | 95 | 0.020 |
Why?
| | Thyrotropin, beta Subunit | 1 | 2011 | 5 | 0.020 |
Why?
| | Glycoprotein Hormones, alpha Subunit | 1 | 2011 | 22 | 0.020 |
Why?
| | Tumor Burden | 1 | 2012 | 284 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2011 | 79 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1668 | 0.020 |
Why?
| | Butadienes | 1 | 2009 | 36 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2012 | 453 | 0.020 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2009 | 195 | 0.020 |
Why?
| | Nitriles | 1 | 2009 | 160 | 0.020 |
Why?
| | Benzamides | 1 | 2009 | 195 | 0.020 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2009 | 168 | 0.020 |
Why?
| | Male | 3 | 2012 | 63045 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2009 | 797 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2009 | 573 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2009 | 345 | 0.020 |
Why?
| | Drug Delivery Systems | 1 | 2009 | 327 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2009 | 813 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2011 | 1404 | 0.010 |
Why?
| | Luciferases | 1 | 2004 | 147 | 0.010 |
Why?
| | Immunoprecipitation | 1 | 2004 | 157 | 0.010 |
Why?
| | Protein Kinase Inhibitors | 1 | 2009 | 880 | 0.010 |
Why?
| | Protein Binding | 1 | 2009 | 2110 | 0.010 |
Why?
| | Weight Gain | 1 | 2004 | 504 | 0.010 |
Why?
| | Female | 2 | 2019 | 68268 | 0.010 |
Why?
| | Aged | 1 | 2019 | 21976 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 30923 | 0.010 |
Why?
|
|
Sharma's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|